A Case Management Algorithm for Women Victims of Violence (VIGITRAUMA)

May 11, 2026 updated by: University Hospital, Lille

Effectiveness of a Case Management Algorithm on Clinical Outcome After Consultations Requested in a Clinical Forensic Medicine Unit by Female Victims of Violence

A considerable body of research has demonstrated that women who are victims of interpersonal violence are at substantially elevated risk for the development of post-traumatic stress disorder (PTSD). In France, victims can request a medico-legal examination in a clinical forensic medicine unit. Although these units are also a place for initial psychological examination, women often don't attend future scheduled appointments. Decision-making algorithm using phone contact are effective in suicide prevention. Our aim is to assess the effectiveness of case management algorithm using early phone contact compared to a control group treated as usual on clinical outcome after consultation requested in a clinical forensic medicine unit by female victims of violence.

Method: Prospective, multicenter, open-label, randomized controlled clinical trial, for women victims of violence. Victims randomized in VIGITRAUMA group will be contacted by phone at 3 weeks after the consultation in a clinical forensic medicine unit, and a second phone call can be done. If the subject is not contacted after the second phone call, he will receive a postcard.

Control group will benefit from usual follow-up.

All the subjects included will be then evaluated at 3 months, 6 months and 1 year during a phone call.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

756

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Amiens, France
        • Not yet recruiting
        • University Hospital, Amiens
        • Principal Investigator:
          • Cécile MANAOUIL
        • Sub-Investigator:
          • Gaetan PRISSETTE
      • Boulogne-sur-Mer, France
        • Not yet recruiting
        • General Hospital, Boulogne sur Mer
        • Principal Investigator:
          • Stéphane CHOCHOIS
      • Caen, France
        • Not yet recruiting
        • University Hospital, Caen
        • Principal Investigator:
          • Grégoire MOUTEL
      • Creil, France
        • Not yet recruiting
        • General Hospital, Creil
        • Principal Investigator:
          • Georges PATRU
        • Sub-Investigator:
          • Marie-Laure CLINET
      • Lille, France
        • Recruiting
        • University Hospital, Lille
        • Principal Investigator:
          • Yann DELANNOY
      • Rouen, France
        • Not yet recruiting
        • University Hospital, Rouen
        • Principal Investigator:
          • Gilles TOURNEL
      • Saint-Quentin, France
        • Not yet recruiting
        • General Hospital, Saint-Quentin
        • Principal Investigator:
          • Fabien DELFORGE
      • Valenciennes, France
        • Not yet recruiting
        • General Hospital, Valenciennes
        • Principal Investigator:
          • Eric LAURIER

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Women
  • 18 years and older
  • Consultation requested in a clinical forensic medicine unit after being victim of violence
  • The person was exposed to: death, threatened death, actual or threatened serious injury, or actual or threatened sexual violence (PTSD criterion A - DSM -5)
  • With social insurance
  • Consent to participate to the study

Exclusion Criteria:

  • Do no consent to participate to the study
  • Intrafamilial or intimate partner violence
  • Do not speak french

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Vigitrauma

Contact by phone at 3 weeks after the consultation in a clinical forensic medicine unit, and a second phone call if necessary.

If the subject is not contacted after the second phone call, he will receive a postcard.

Case management algorithm using early phone contact
No Intervention: Control group
Usual follow-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Outcome
Time Frame: 3 months
Rate of patients with a Clinical Global Impression (CGI) severity scale < 4
3 months
Clinical Outcome
Time Frame: 6 months
Rate of patients with a Clinical Global Impression (CGI) severity scale < 4
6 months
Clinical Outcome
Time Frame: 12 months
Rate of patients with a Clinical Global Impression (CGI) severity scale < 4
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severity of post-traumatic stress disorder symptoms
Time Frame: 3 months, 6 months and 12 months
Post-traumatic stress disorder Checklist Scale-5
3 months, 6 months and 12 months
General psychopathology
Time Frame: 3 months, 6 months and 12 months
French version of Mini International Neuropsychiatric Interview (DSM 5)
3 months, 6 months and 12 months
Severity of somatic symptoms
Time Frame: 3 months, 6 months and 12 months
Physical Health Questionnaire (PHQ-15)
3 months, 6 months and 12 months
Medical cost
Time Frame: 12 months
Nnumber of hospitalizations, consultations, and drugs consummation
12 months
Judicial outcome
Time Frame: 12 months
Number of days of temporary inability to work
12 months
Suicidal ideation intensity
Time Frame: 12 months
The Beck Scale for Suicide Ideation (SSI) The Scale for Suicide Ideation (SSI; Beck, et al., 1979) is a brief 21-item scale that assesses the person's current intensity of attitudes, plans, and behaviors to commit suicide.
12 months
Number of suicide attempters
Time Frame: 12 months
Suicide risk
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Arnaud Leroy, MD, University Hospital, Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 6, 2021

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

June 4, 2021

First Submitted That Met QC Criteria

July 6, 2021

First Posted (Actual)

July 7, 2021

Study Record Updates

Last Update Posted (Actual)

May 14, 2026

Last Update Submitted That Met QC Criteria

May 11, 2026

Last Verified

June 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-Traumatic Stress Disorder

Subscribe